How do you approach maintenance therapy for relapsed follicular lymphoma?  

Specifically, do you consider repeating maintenance therapy after second line therapy if a patient had already received 2 years of maintenance rituximab with frontline therapy? Does it matter if the relapse is > 12 months or < 12 months after frontline therapy?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Berkshire Hem Onc PC
What about maintenance obinutuzumab as an alternat...
Medical Oncologist at University of Mississippi Medical Center
Data for obinutuzumab comes from GADOLIN. In patie...
Sign in or Register to read more